OBJECTIVE:To determine the content of shikonin in Arnebia euchroma by HPCE-UV.METHODS:The separation was performed on uncoated fused silica capillary column (53 cm?50 ?m ID,46 cm effective length).2.0 mmol?L-1 H3BO3,6.0 mmol?L-1 triethylamine buffer solution and 5.0 mmol?L-1?-CD was used as background electrolyte,14 kV separation voltage and time of gravity injection 15 s (25 cm).The detection wavelength was set at 516 nm.RESULTS:The linear range of shikonin was 7.2～36.0 ?g?mL-1(r=0.999 0) with an average recovery of 100.15%(RSD=1.68%,n=6).CONCLUSION:The method is convenient,rapid,accurate and reliable for the content determination of shikonin in A.euchroma.

Objective: This study aims to determine the prevalence of overweight and obesity and associated early life factors among children aged 2 to 6 years in a community in Guangzhou. Methods: A stratified cluster sampling was used to select 922 children from one community in Guangzhou in 2018. The survey included a questionnaire survey and physical examination. Logistic regression analyses were performed to examine the relationship of early-life factors and obesity. Results: The prevalence of overweight and obesity was 13.4% in 922 children(16.1% in boys and 10.1% in girls). The sex difference in prevalence of overweight and obesity was statistically significant(Z=2.69, P<0.05). Overweight and obesity was found significantly higher in children with large for gestational age, caesarean section, artificial feeding within 6 months, maternal pre-pregnancy overweight and obesity, maternal excessive weight gain(P<0.01). Large for gestational age (OR=2.62, 95%CI=1.42-4.82), caesarean section(OR=1.59, 95%CI=1.08-2.36), artificial feeding within 6 months(OR=2.00, 95%CI=1.19-3.37), maternal pre-pregnancy overweight or obesity(OR=1.97, 95%CI=1.08-3.58), and excessive gestational weight gain (OR=2.07, 95%CI=1.26-3.39) was positively associated with childhood overweight obesity(P<0.05). Maternal pre-pregnancy underweight was negatively associated with childhood overweight obesity(OR=0.51, 95%CI=0.29-0.88, P<0.05). Conclusion Early-life risk factors are positively associated with the risk of overweight and obesity in later childhood, including large gestational age, caesarean section, artificial feeding within 6 months, maternal pre-pregnancy overweight and excessive gestational weight gain, while maternal pre-pregnancy underweight associates with low risk of child overweight and obesity. These findings suggest that early intervention to these modifiable risk factors could make a significant contribution to childhood obesity prevention.

Objective:To investigate the pharmacokinetics of sugammadex in reversal of rocuronium-induced muscle relaxant residual in infants and young children undergoing daytime surgery.Methods:One hundred and four pediatric patients of either sex, aged 3-36 months, of American Society of Anesthesiologists Physical Status classification Ⅱ, with body mass index of 18.5-28.0 kg/m 2, diagnosed with oblique inguinal hernia and/or hydrocele, scheduled for laparoscopic high ligation of hernia sac and/or high ligation of sphingoid surgery, were included in the study. Intraoperative neuromuscle relaxation was assessed by transdermal stimulation of the ulnar nerve in the wrist using a TOF Guard monitor. Rocuronium 0.9 mg/kg, propofol 3 mg/kg, and sufentanyl 0.5 μg/kg were intravenously injected for anesthesia induction, and propofol 6-8 mg·kg -1·h -1 was intravenously infused to maintain anesthesia. The pediatric patients were divided into Ⅰgroup and Ⅱ group according to the degree of postoperative neuromuscular block. In group Ⅰ, sugammadex 2 mg/kg was intravenously injected when TOF returned to T 2 recurrence. In group Ⅱ, sugammadex 4 mg/kg was intravenously injected when the single stimulation count was 1 or 2 after tetanic stimulation. At 2 and 10 min after rocuronium administration, at the end of operation, 2 and 10 min after sugammadex administration, and when the children met the standard of leaving the resuscitation room, venous blood samples were collected for determination of plasma concentrations of rocuronium and sugammadex using ultra-high performance liquid chromatography-mass spectrometry. Pharmacokinetic parameters were determined using the Pheonix WinNonlin software. The onset of rocuronium and time for recovery of TOF ratio to 90% were recorded. Results:The pharmacokinetics of sugammadex was fitted to the nonlinear mixed-effect satrioventricular model.There was no significant difference in the peak concentration, area under the drug concentration-time curve, elimination half-life, apparent clearance, apparent volume of distribution, mean retention time, and time for TOF ratio returning to 90% between the two groups ( P> 0.05). Conclusions:The pharmacokinetics of sugammadex in reversal of rocuronium-induced muscle relaxant residual is fitted to a nonlinear mixed-effect satrioventricular model, and sugammadex 2 and 4 mg/kg have similar pharmacokinetics in infants and young children undergoing daytime surgery.